Growth rate alterations of human colorectal cancer cells by 157 gut bacteria

References

• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533–e. doi:10.1371/journal.pbio.1002533.
   PubMed Web of Science ®Google Scholar
• Rajilić-Stojanović M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38:996–1047. doi:10.1111/1574-6976.12075.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65. doi:10.1038/nature08821.
   PubMed Web of Science ®Google Scholar
• Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683–691. doi:10.1136/gutjnl-2015-310912.
   PubMed Web of Science ®Google Scholar
• Gao R, Kong C, Huang L, Li H, Qu X, Liu Z, Lan P, Wang J, Qin H. Mucosa-associated microbiota signature in colorectal cancer. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2017;36:2073–2083. doi:10.1007/s10096-017-3026-4.
   PubMed Web of Science ®Google Scholar
• Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10:575–582. doi:10.1038/nrmicro2819.
   PubMed Web of Science ®Google Scholar
• Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol. 2015;6:20. doi:10.3389/fmicb.2015.00020.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Dutilh BE, Hall N, Peters WHM, Roelofs R, Boleij A, Tjalsma H. Towards the human colorectal cancer microbiome. PloS One. 2011;6:e20447–e. doi:10.1371/journal.pone.0020447.
   PubMed Web of Science ®Google Scholar
• Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679–689. doi:10.1038/s41591-019-0406-6.
   PubMed Web of Science ®Google Scholar
• Xu K, Jiang B. Analysis of Mucosa-associated microbiota in colorectal cancer. Med Sci Monit Int Med J Exp Clin Res. 2017;23:4422–4430. doi:10.12659/MSM.904220.
   Web of Science ®Google Scholar
• Donia MS. A toolbox for microbiome engineering. Cell Syst. 2015;1:21–23. doi:10.1016/j.cels.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Foo JL, Ling H, Lee YS, Chang MW. Microbiome engineering: current applications and its future. Biotechnol J. 2017;12. doi:10.1002/biot.201600099.
   Web of Science ®Google Scholar
• Garcia-Jimenez B, de la Rosa T, Wilkinson MD. MDPbiome: microbiome engineering through prescriptive perturbations. Bioinformatics (Oxford, England). 2018;34:i838–i47. doi:10.1093/bioinformatics/bty562.
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL. Microbiome engineering. Nature. 2015;518:S10. doi:10.1038/518S10a.
   PubMed Web of Science ®Google Scholar
• Bernardes N, Seruca R, Chakrabarty AM, Fialho AM. Microbial-based therapy of cancer: current progress and future prospects. Bioeng Bugs. 2010;1:178–190. doi:10.4161/bbug.1.3.10903.
   PubMedGoogle Scholar
• Song S, Vuai MS, Zhong M. The role of bacteria in cancer therapy - enemies in the past, but allies at present. Infect Agent Cancer. 2018;13:9. doi:10.1186/s13027-018-0180-y.
   PubMed Web of Science ®Google Scholar
• Lukasiewicz K, Fol M. Microorganisms in the treatment of cancer: advantages and limitations. J Immunol Res. 2018;2018:2397808. doi:10.1155/2018/2397808.
   PubMed Web of Science ®Google Scholar
• Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, et al. White paper on microbial anti-cancer therapy and prevention. J ImmunoTher Cancer. 2018;6:78. doi:10.1186/s40425-018-0381-3.
   PubMed Web of Science ®Google Scholar
• Kramer MG, Masner M, Ferreira FA, Hoffman RM. Bacterial therapy of cancer: promises, limitations, and insights for future directions. Front Microbiol. 2018;9:16. doi:10.3389/fmicb.2018.00016.
   PubMed Web of Science ®Google Scholar
• Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, Jovov B, Abdo Z, Sandler RS, Keku TO. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes. 2010;1:138–147. doi:10.4161/gmic.1.3.12360.
   PubMed Web of Science ®Google Scholar
• Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PloS One. 2012;7:e39743. doi:10.1371/journal.pone.0039743.
   PubMed Web of Science ®Google Scholar
• Flemer B, Lynch DB, Brown JM, Jeffery IB, Ryan FJ, Claesson MJ, O'Riordain M, Shanahan F, O'Toole PW. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut. 2017;66:633–643. doi:10.1136/gutjnl-2015-309595.
   PubMed Web of Science ®Google Scholar
• Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Bohm J, Brunetti F, Habermann N, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10:766. doi:10.15252/msb.20145645.
   PubMed Web of Science ®Google Scholar
• Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. Isme J. 2012;6:320–329. doi:10.1038/ismej.2011.109.
   PubMed Web of Science ®Google Scholar
• Hale VL, Jeraldo P, Mundy M, Yao J, Keeney G, Scott N, Cheek EH, Davidson J, Greene M, Martinez C, et al. Synthesis of multi-omic data and community metabolic models reveals insights into the role of hydrogen sulfide in colon cancer. Methods (San Diego, Calif). 2018;149:59–68. doi:10.1016/j.ymeth.2018.04.024.
   PubMed Web of Science ®Google Scholar
• Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis Offl Publ Infect Dis Soc Am. 2015;60:208–215. doi:10.1093/cid/ciu787.
   Google Scholar
• Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22:292–298. doi:10.1101/gr.126573.111.
   PubMed Web of Science ®Google Scholar
• Boleij A, Dutilh BE, Kortman GA, Roelofs R, Laarakkers CM, Engelke UF, Tjalsma H. Bacterial responses to a simulated colon tumor microenvironment. MCP. 2012;11:851–862. doi:10.1074/mcp.M112.019315.
   Google Scholar
• Tjalsma H, Bolhuis A, Jongbloed JD, Bron S, van Dijl JM. Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. MMBR. 2000;64:515–547.
   Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195–206. doi:10.1016/j.chom.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Fardini Y, Wang X, Temoin S, Nithianantham S, Lee D, Shoham M, Han YW. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol. 2011;82:1468–1480. doi:10.1111/j.1365-2958.2011.07905.x.
   PubMed Web of Science ®Google Scholar
• Chen Y, Peng Y, Yu J, Chen T, Wu Y, Shi L, Li Q, Wu J, Fu X. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade. Oncotarget. 2017;8:31802–31814. doi:10.18632/oncotarget.15992.
   PubMedGoogle Scholar
• Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB, Levine MM. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest. 1993;92:1412–1417. doi:10.1172/JCI116717.
   PubMed Web of Science ®Google Scholar
• Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A. 1990;87:7839–7843. doi:10.1073/pnas.87.20.7839.
   PubMed Web of Science ®Google Scholar
• Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PloS One. 2009;4:e5517. doi:10.1371/journal.pone.0005517.
   PubMed Web of Science ®Google Scholar
• Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA, Rabizadeh S, Golub JE, Mathews LE, Shin J, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708–1718. doi:10.1128/IAI.00814-08.
   PubMed Web of Science ®Google Scholar
• Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392–400. doi:10.1053/gast.2003.50047.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A. 2010;107:11537–11542. doi:10.1073/pnas.1001261107.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (New York, NY). 2012;338:120–123. doi:10.1126/science.1224820.
   Google Scholar
• Wilson MR, Jiang Y, Villalta PW, Stornetta A, Boudreau PD, Carra A, Brennan CA, Chun E, Ngo L, Samson LD, et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science (New York, NY). 2019;363.
   Google Scholar
• Wattam AR, Davis JJ, Assaf R, Boisvert S, Brettin T, Bun C, Conrad N, Dietrich EM, Disz T, Gabbard JL, et al. Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center. Nucleic Acids Res. 2017;45:D535–d42. doi:10.1093/nar/gkw1017.
   PubMed Web of Science ®Google Scholar
• Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis Offl Publ Infect Dis Soc Am. 2011;53:870–878. doi:10.1093/cid/cir609.
   PubMed Web of Science ®Google Scholar
• Wentling GK, Metzger PP, Dozois EJ, Chua HK, Krishna M. Unusual bacterial infections and colorectal carcinoma–Streptococcus bovis and Clostridium septicum: report of three cases. Dis Colon Rectum. 2006;49:1223–1227. doi:10.1007/s10350-006-0576-4.
   PubMed Web of Science ®Google Scholar
• Schaaf RE, Jacobs N, Kelvin FM, Gallis HA, Akwari O, Thompson WM. Clostridium septicum infection associated with colonic carcinoma and hematologic abnormality. Radiology. 1980;137:625–627. doi:10.1148/radiology.137.3.6934562.
   PubMed Web of Science ®Google Scholar
• Sidhu JS, Mandal A, Virk J, Gayam V. Early detection of colon cancer following incidental finding of Clostridium septicum bacteremia. J Invest Med High Impact Case Rep. 2019;7:2324709619832050. doi:10.1177/2324709619832050.
   Web of Science ®Google Scholar
• Zheng Y, Luo Y, Lv Y, Huang C, Sheng Q, Zhao P, Ye J, Jiang W, Liu L, Song X, et al. Clostridium difficile colonization in preoperative colorectal cancer patients. Oncotarget. 2017;8:11877–11886. doi:10.18632/oncotarget.14424.
   PubMedGoogle Scholar
• Fukugaiti MH, Ignacio A, Fernandes MR, Ribeiro Junior U, Nakano V, Avila-Campos MJ. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients. Braz J Microbiol [Publ Braz Soc Microbiol]. 2015;46:1135–1140. doi:10.1590/S1517-838246420140665.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Tsunoda A, Sibusawa M, Tsunoda Y, Kusano M, Fukuchi K, Yamanaka M, Kushima M, Nomoto K, Morotomi M. The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep. 2000;7:977–982. doi:10.3892/or.7.5.977.
   PubMed Web of Science ®Google Scholar
• Kato-Kataoka A, Nishida K, Takada M, Kawai M, Kikuchi-Hayakawa H, Suda K, Ishikawa H, Gondo Y, Shimizu K, Matsuki T, et al. Fermented milk containing lactobacillus casei strain shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Appl Environ Microbiol. 2016;82:3649–3658. doi:10.1128/AEM.04134-15.
   PubMed Web of Science ®Google Scholar
• Morishita T, Fukada T, Shirota M, Yura T. Genetic basis of nutritional requirements in Lactobacillus casei. J Bacteriol. 1974;120:1078–1084. doi:10.1128/JB.120.3.1078-1084.1974.
   PubMed Web of Science ®Google Scholar
• Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54:1469–1476. doi:10.1099/ijs.0.02873-0.
   PubMed Web of Science ®Google Scholar
• Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, DeStefano Shields CE, Hechenbleikner EM, Huso DL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science (New York, NY). 2018;359:592–597. doi:10.1126/science.aah3648.
   Google Scholar
• Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PloS One. 2013;8:e70803. doi:10.1371/journal.pone.0070803.
   PubMed Web of Science ®Google Scholar
• Dingemanse C, Belzer C, van Hijum SA, Gunthel M, Salvatori D, den Dunnen JT, Kuijper EJ, Devilee P, de Vos WM, van Ommen GB, et al. Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis. 2015;36:1388–1396. doi:10.1093/carcin/bgv120.
   PubMed Web of Science ®Google Scholar
• Knapp O, Maier E, Mkaddem SB, Benz R, Bens M, Chenal A, Geny B, Vandewalle A, Popoff MR. Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon. 2010;55:61–72. doi:10.1016/j.toxicon.2009.06.037.
   PubMed Web of Science ®Google Scholar
• Wust J, Hardegger U. Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile. Antimicrob Agents Chemother. 1983;23:784–786. doi:10.1128/AAC.23.5.784.
   PubMed Web of Science ®Google Scholar
• Boleij A, Muytjens CM, Bukhari SI, Cayet N, Glaser P, Hermans PW, Swinkels DW, Bolhuis A, Tjalsma H.Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis. 2011;203:1101–1109. doi:10.1093/infdis/jiq169.
   PubMed Web of Science ®Google Scholar
• Tripodi MF, Fortunato R, Utili R, Triassi M, Zarrilli R. Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2005;11:814–819. doi:10.1111/j.1469-0691.2005.01248.x.
   PubMed Web of Science ®Google Scholar
• Tripodi MF, Adinolfi LE, Ragone E, Durante Mangoni E, Fortunato R, Iarussi D, Ruggiero G, Utili R. Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis Offl Publ Infect Dis Soc Am. 2004;38:1394–1400. doi:10.1086/392503.
   Google Scholar
• Ogawa Y, Ooka T, Shi F, Ogura Y, Nakayama K, Hayashi T, Shimoji Y. The genome of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas, reveals new insights into the evolution of firmicutes and the organism’s intracellular adaptations. J Bacteriol. 2011;193:2959–2971. doi:10.1128/JB.01500-10.
   PubMed Web of Science ®Google Scholar
• Taddese R, Belzer C, Aalvink S, de Jonge MI, Nagtegaal ID, Dutilh BE, Boleij A. Bacterial zombies and ghosts: production of inactivated gram-positive and gram-negative species with preserved cellular morphology and cytoplasmic content. bioRxiv. 2018;458158.
   Google Scholar
• Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknaes M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2:e71. doi:10.1038/oncsis.2013.35.
   PubMed Web of Science ®Google Scholar
• Eijkelenboom A, Kamping EJ, Kastner-van Raaij AW, Hendriks-Cornelissen SJ, Neveling K, Kuiper RP, Hoischen A, Nelen MR, Ligtenberg MJ, Tops BB. Reliable next-generation sequencing of formalin-fixed, paraffin-embedded tissue using single molecule tags. JMD. 2016;18:851–863. doi:10.1016/j.jmoldx.2016.06.010.
   Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. doi:10.1016/0022-1759(83)90303-4.
   PubMed Web of Science ®Google Scholar
• van der Maaten LH, Geoffrey. Visualizing data using t-SNE. J Mach Learn Res. 2008;9:2579–2605.
   Web of Science ®Google Scholar
• Bentley JL. Multidimensional binary search trees used for associative searching. Commun ACM. 1975;18:509–517.
   Web of Science ®Google Scholar
• Ballard J, Sokolov Y, WL Y, BL K, Tweten RK. Activation and mechanism of Clostridium septicum alpha toxin. Mol Microbiol. 1993;10:627–634.
   PubMed Web of Science ®Google Scholar
• Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 2008;9:75. doi:10.1186/1471-2164-9-75.
   PubMed Web of Science ®Google Scholar
• Poisson Distribution. Univariate Discrete Distributions. 2005;156–207.
   Google Scholar
• Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59–74. doi:10.1099/0022-1317-36-1-59.
   PubMed Web of Science ®Google Scholar
• Ma CT, Luo HS, Gao F, Tang QC, Chen W. Fusobacterium nucleatum promotes the progression of colorectal cancer by interacting with E-cadherin. Oncol Lett. 2018;16:2606–2612. doi:10.3892/ol.2018.8947.
   PubMed Web of Science ®Google Scholar
• Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes. 2014;5:675–680. doi:10.4161/19490976.2014.969989.
   PubMed Web of Science ®Google Scholar
• Fais T, Delmas J, Barnich N, Bonnet R, Dalmasso G. Colibactin: more than a new bacterial toxin. Toxins. 2018;10. doi:10.3390/toxins10040151.
   Web of Science ®Google Scholar
• Dean P, Kenny B. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol. 2009;12:101–109. doi:10.1016/j.mib.2008.11.006.
   PubMed Web of Science ®Google Scholar
• Singh AP, Sharma S, Pagarware K, Siraji RA, Ansari I, Mandal A, Walling P, Aijaz S. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation. Sci Rep. 2018;8:3719. doi:10.1038/s41598-018-22017-1.
   PubMed Web of Science ®Google Scholar
• Wassenaar TM. E. coli and colorectal cancer: a complex relationship that deserves a critical mindset. Crit Rev Microbiol. 2018;44:619–632. doi:10.1080/1040841X.2018.1481013.
   PubMed Web of Science ®Google Scholar
• Bossuet-Greif N, Vignard J, Taieb F, Mirey G, Dubois D, Petit C, Oswald E, Nougayrede JP. The colibactin genotoxin generates DNA Interstrand cross-links in infected cells. mBio. 2018;9.
   Web of Science ®Google Scholar
• Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 2013;105:1907–1911. doi:10.1093/jnci/djt300.
   PubMed Web of Science ®Google Scholar
• Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, Gao R, Liu M, Yin M, Pan C, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-kappaB, and up-regulating expression of MicroRNA-21. Gastroenterology. 2017;152:851–66.e24. doi:10.1053/j.gastro.2016.11.018.
   PubMed Web of Science ®Google Scholar
• Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299–306. doi:10.1101/gr.126516.111.
   PubMed Web of Science ®Google Scholar
• Liu J, Hsieh CL, Gelincik O, Devolder B, Sei S, Zhang S, Lipkin SM, Chang YF. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. J Proteomics. 2019;195:125–137. doi:10.1016/j.jprot.2018.12.029.
   PubMed Web of Science ®Google Scholar
• Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, Li M, Sojar HT, Genco RJ, Kuramitsu HK, Deng CX. Identification and characterization of a novel adhesin unique to oral fusobacteria. J Bacteriol. 2005;187:5330–5340. doi:10.1128/JB.187.15.5330-5340.2005.
   PubMed Web of Science ®Google Scholar
• Sears CL. The toxins of Bacteroides fragilis. Toxicon. 2001;39:1737–1746. doi:10.1016/S0041-0101(01)00160-X.
   PubMed Web of Science ®Google Scholar
• Jans C, Boleij A. The road to infection: host-microbe interactions defining the pathogenicity of Streptococcus bovis/Streptococcus equinus complex members. Front Microbiol. 2018;9:603. doi:10.3389/fmicb.2018.00603.
   PubMed Web of Science ®Google Scholar
• Boleij A, Tjalsma H. The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect Dis. 2013;13:719–724. doi:10.1016/S1473-3099(13)70107-5.
   PubMed Web of Science ®Google Scholar
• Kumar R, Herold JL, Schady D, Davis J, Kopetz S, Martinez-Moczygemba M, Murray BE, Han F, Li Y, Callaway E, et al. Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development. PLoS Pathog. 2017;13:e1006440. doi:10.1371/journal.ppat.1006440.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang W, Evans PM, Chen X, He X, Liu C. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem. 2006;281:17751–17757. doi:10.1074/jbc.M600831200.
   PubMed Web of Science ®Google Scholar
• Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019;47:D941–d7. doi:10.1093/nar/gky1015.
   PubMed Web of Science ®Google Scholar
• Sgro GG, Oka GU, Souza DP, Cenens W, Bayer-Santos E, Matsuyama BY, Bueno NF, Dos Santos TR, Alvarez-Martinez CE, Salinas RK, et al. Bacteria-killing Type IV secretion systems. Front Microbiol. 2019;10:1078. doi:10.3389/fmicb.2019.01078.
   PubMed Web of Science ®Google Scholar
• Kiersztyn B, Siuda W, Chrost RJ. Persistence of bacterial proteolytic enzymes in lake ecosystems. FEMS Microbiol Ecol. 2012;80:124–134. doi:10.1111/j.1574-6941.2011.01276.x.
   PubMed Web of Science ®Google Scholar
• Battaglia-Hsu SF, Akchiche N, Noel N, Alberto JM, Jeannesson E, Orozco-Barrios CE, Martinez-Fong D, Daval JL, Gueant JL. Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE. Proc Natl Acad Sci U S A. 2009;106:21930–21935. doi:10.1073/pnas.0811794106.
   PubMed Web of Science ®Google Scholar
• Wexler AG, Schofield WB, Degnan PH, Folta-Stogniew E, Barry NA, Goodman AL. Human gut Bacteroides capture vitamin B12 via cell surface-exposed lipoproteins. Elife. 2018;7. doi:0.7554/eLife.37138.
   Web of Science ®Google Scholar
• Patel D, Witt SN. Ethanolamine and Phosphatidylethanolamine: partners in Health and Disease. Oxid Med Cell Longev. 2017;2017:4829180. doi:10.1155/2017/4829180.
   PubMed Web of Science ®Google Scholar
• Tsoy O, Ravcheev D, Mushegian A. Comparative genomics of ethanolamine utilization. J Bacteriol. 2009;191:7157–7164. doi:10.1128/JB.00838-09.
   PubMed Web of Science ®Google Scholar
• Kaval KG, Garsin DA. Ethanolamine utilization in bacteria. mBio. 2018;9.  doi:0.1128/mBio.00066-18.
   Web of Science ®Google Scholar
• Kendall MM, Gruber CC, Parker CT, Sperandio V. Ethanolamine controls expression of genes encoding components involved in interkingdom signaling and virulence in enterohemorrhagic Escherichia coli O157:H7. mBio. 2012;3. doi:10.1128/mBio.00050-12.
   Web of Science ®Google Scholar
• van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J, Taylor-Weiner A, Kester L, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161:933–945. doi:10.1016/j.cell.2015.03.053.
   PubMed Web of Science ®Google Scholar